Cancer Biomarkers

Cancer biomarkers are molecules, genes, or proteins found in tissues, blood, or other body fluids that indicate the presence or progression of cancer. These biomarkers can be diagnostic, helping to detect cancer early, or prognostic, predicting the course of the disease. Predictive biomarkers guide treatment decisions by indicating how a patient might respond to specific therapies, such as targeted treatments or immunotherapies. Common biomarkers include HER2 in breast cancer, PSA in prostate cancer, and CA-125 for ovarian cancer. Advances in biomarker research are improving personalized medicine, allowing treatments to be tailored to an individual’s unique cancer profile. Additionally, cancer biomarkers aid in monitoring treatment efficacy and detecting recurrence, making them crucial tools in cancer management and therapy development.

    Related Conference of Cancer Biomarkers

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in